Sigma Healthcare Limited (ASX: SIG) confirmed that it remain on target to deliver FY20 Underlying EBITDA guidance in the range of $46 million to $47 million.
The one-off costs linked with the transformation of the company’s business shall give rise to inadequate franking credits to pay a fully franked final dividend in respect of FY2020.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.